Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Neurosci ; 35(49): 16171-9, 2015 Dec 09.
Artigo em Inglês | MEDLINE | ID: mdl-26658868

RESUMO

AMPA-type glutamate receptors are ligand-gated cation channels responsible for a majority of the fast excitatory synaptic transmission in the brain. Their behavior and calcium permeability depends critically on their subunit composition and the identity of associated auxiliary proteins. Calcium-permeable AMPA receptors (CP-AMPARs) contribute to various forms of synaptic plasticity, and their dysfunction underlies a number of serious neurological conditions. For CP-AMPARs, the prototypical transmembrane AMPAR regulatory protein stargazin, which acts as an auxiliary subunit, enhances receptor function by increasing single-channel conductance, slowing channel gating, increasing calcium permeability, and relieving the voltage-dependent block by endogenous intracellular polyamines. We find that, in contrast, GSG1L, a transmembrane auxiliary protein identified recently as being part of the AMPAR proteome, acts to reduce the weighted mean single-channel conductance and calcium permeability of recombinant CP-AMPARs, while increasing polyamine-dependent rectification. To examine the effects of GSG1L on native AMPARs, we manipulated its expression in cerebellar and hippocampal neurons. Transfection of GSG1L into mouse cultured cerebellar stellate cells that lack this protein increased the inward rectification of mEPSCs. Conversely, shRNA-mediated knockdown of endogenous GSG1L in rat cultured hippocampal pyramidal neurons led to an increase in mEPSC amplitude and in the underlying weighted mean single-channel conductance, revealing that GSG1L acts to suppress current flow through native CP-AMPARs. Thus, our data suggest that GSG1L extends the functional repertoire of AMPAR auxiliary subunits, which can act not only to enhance but also diminish current flow through their associated AMPARs. SIGNIFICANCE STATEMENT: Calcium-permeable AMPA receptors (CP-AMPARs) are an important group of receptors for the neurotransmitter glutamate. These receptors contribute to various forms of synaptic plasticity, and alterations in their expression or regulation are also seen in a number of serious neurological conditions, including stroke, motor neuron disease, and cocaine addiction. Several groups of auxiliary transmembrane proteins have been described that enhance the function and cell-surface expression of AMPARs. We now report that the recently identified auxiliary protein GSG1L decreases weighted mean channel conductance and calcium permeability of CP-AMPARs while increasing polyamine-dependent rectification by diminishing outward current. Our experiments reveal that GSG1L is an auxiliary subunit that can markedly suppress CP-AMPAR function, in both recombinant systems and central neurons.


Assuntos
Cálcio/metabolismo , Claudinas/metabolismo , Potenciais Pós-Sinápticos Excitadores/fisiologia , Neurônios/fisiologia , Receptores de AMPA/fisiologia , Animais , Animais Recém-Nascidos , Células Cultivadas , Claudinas/genética , Agonistas de Aminoácidos Excitatórios/farmacologia , Potenciais Pós-Sinápticos Excitadores/efeitos dos fármacos , Feminino , Ácido Glutâmico/farmacologia , Hipocampo/citologia , Humanos , Camundongos , Camundongos Endogâmicos C57BL , Neurônios/efeitos dos fármacos , Antagonistas Nicotínicos/farmacologia , Poliaminas/farmacologia , Ratos , Ratos Sprague-Dawley , Espermina/farmacologia
2.
J Neurosci ; 33(33): 13431-5, 2013 Aug 14.
Artigo em Inglês | MEDLINE | ID: mdl-23946400

RESUMO

Inhibition of GABAA receptors by Cu(2+) has been appreciated for some time, but differences between synaptic and extrasynaptic GABAA receptors have not been explored. We show that Cu(2+) potently blocks steady-state GABA currents mediated by extrasynaptic δ subunit-containing GABAA receptors (δ-GABAARs) with an IC50 of 65 nM. This compares with an IC50 of 85 µM for synaptic γ subunit-containing GABAARs (γ-GABAARs). To test the significance of this subunit selectivity, we examined the blocking action of Cu(2+) on neurons of the mouse cerebellum and striatum, brain regions that are known to express both types of receptor. Cu(2+) was shown to significantly reduce tonic inhibition mediated by extrasynaptic δ-GABAARs with little action on phasic inhibition mediated by conventional synaptic γ-GABAARs. We speculate on the implications of these observations for conditions, such as Wilson's disease, that can involve raised Cu(2+) levels in the brain.


Assuntos
Cerebelo/metabolismo , Cobre/metabolismo , Corpo Estriado/metabolismo , Receptores de GABA-A/metabolismo , Animais , Cerebelo/efeitos dos fármacos , Cobre/farmacologia , Corpo Estriado/efeitos dos fármacos , Células HEK293 , Humanos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Técnicas de Patch-Clamp , Sinapses/efeitos dos fármacos , Sinapses/metabolismo , Transfecção
3.
J Neurosci ; 32(11): 3887-97, 2012 Mar 14.
Artigo em Inglês | MEDLINE | ID: mdl-22423109

RESUMO

High-affinity extrasynaptic GABA(A) receptors are persistently activated by the low ambient GABA levels that are known to be present in extracellular space. The resulting tonic conductance generates a form of shunting inhibition that is capable of altering cellular and network behavior. It has been suggested that this tonic inhibition will be enhanced by neurosteroids, antiepileptics, and sedative/hypnotic drugs. However, we show that the ability of sedative/hypnotic drugs to enhance tonic inhibition in the mouse cerebellum will critically depend on ambient GABA levels. For example, we show that the intravenous anesthetic propofol enhances tonic inhibition only when ambient GABA levels are <100 nm. More surprisingly, the actions of the sleep-promoting drug 4,5,6,7-tetrahydroisothiazolo-[5,4-c]pyridin-3-ol (THIP) are attenuated at ambient GABA levels of just 20 nm. In contrast, our data suggest that neurosteroid enhancement of tonic inhibition will be greater at high ambient GABA concentrations. We present a model that takes into account realistic estimates of ambient GABA levels and predicted extrasynaptic GABA(A) receptor numbers when considering the ability of sedative/hypnotic drugs to enhance tonic inhibition. These issues will be important when considering drug strategies designed to target extrasynaptic GABA(A) receptors in the treatment of sleep disorders and other neurological conditions.


Assuntos
Sistemas de Liberação de Medicamentos , Hipnóticos e Sedativos/administração & dosagem , Hipnóticos e Sedativos/metabolismo , Receptores de GABA-A/metabolismo , Sinapses/metabolismo , Animais , Linhagem Celular Transformada , Sistemas de Liberação de Medicamentos/métodos , Células HEK293 , Humanos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Técnicas de Cultura de Órgãos , Sinapses/efeitos dos fármacos , Ácido gama-Aminobutírico/metabolismo
4.
J Neurosci ; 31(2): 753-63, 2011 Jan 12.
Artigo em Inglês | MEDLINE | ID: mdl-21228184

RESUMO

High-affinity extrasynaptic GABA(A) receptors (GABA(A)Rs) are a prominent feature of cerebellar granule neurons and thalamic relay neurons. In both cell types, the presence of synaptic glomeruli would be expected to promote activation of these GABA(A)Rs, contributing to phasic spillover-mediated currents and tonic inhibition. However, the precise role of different receptor subtypes in these two phenomena is unclear. To address this question, we made recordings from neurons in acute brain slices from mice, and from tsA201 cells expressing recombinant GABA(A)Rs. We found that δ subunit-containing GABA(A)Rs of both cerebellar granule neurons and thalamic relay neurons of the lateral geniculate nucleus contributed to tonic conductance caused by ambient GABA but not to spillover-mediated currents. In the presence of a low "ambient" GABA concentration, recombinant "extrasynaptic" δ subunit-containing GABA(A)Rs exhibited profound desensitization, rendering them insensitive to brief synaptic- or spillover-like GABA transients. Together, our results demonstrate that phasic spillover and tonic inhibition reflect the activation of distinct receptor populations.


Assuntos
Receptores de GABA-A/fisiologia , Ácido gama-Aminobutírico/fisiologia , Animais , Linhagem Celular , Cerebelo/citologia , Cerebelo/fisiologia , Humanos , Técnicas In Vitro , Potenciais Pós-Sinápticos Inibidores , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Neurônios/fisiologia , Técnicas de Patch-Clamp , Subunidades Proteicas/fisiologia , Ratos , Receptores de GABA-A/genética , Sinapses/fisiologia , Tálamo/citologia , Tálamo/fisiologia , Transfecção
5.
Nat Commun ; 10(1): 4312, 2019 09 20.
Artigo em Inglês | MEDLINE | ID: mdl-31541113

RESUMO

Desensitization is a canonical property of ligand-gated ion channels, causing progressive current decline in the continued presence of agonist. AMPA-type glutamate receptors (AMPARs), which mediate fast excitatory signaling throughout the brain, exhibit profound desensitization. Recent cryo-EM studies of AMPAR assemblies show their ion channels to be closed in the desensitized state. Here we present evidence that homomeric Q/R-edited AMPARs still allow ions to flow when the receptors are desensitized. GluA2(R) expressed alone, or with auxiliary subunits (γ-2, γ-8 or GSG1L), generates large fractional steady-state currents and anomalous current-variance relationships. Our results from fluctuation analysis, single-channel recording, and kinetic modeling, suggest that the steady-state current is mediated predominantly by conducting desensitized receptors. When combined with crystallography this unique functional readout of a hitherto silent state enabled us to examine cross-linked cysteine mutants to probe the conformation of the desensitized ligand binding domain of functioning AMPAR complexes.


Assuntos
Receptores de AMPA/química , Receptores de AMPA/metabolismo , Biofísica , Cristalografia por Raios X , Ácido Glutâmico , Células HEK293 , Humanos , Cinética , Modelos Moleculares , Estrutura Molecular , Neurociências , Ligação Proteica , Domínios Proteicos , Receptores de AMPA/genética
6.
Cell Rep ; 21(1): 70-83, 2017 Oct 03.
Artigo em Inglês | MEDLINE | ID: mdl-28978485

RESUMO

Inhibitory synaptic transmission requires the targeting and stabilization of GABAA receptors (GABAARs) at synapses. The mechanisms responsible remain poorly understood, and roles for transmembrane accessory proteins have not been established. Using molecular, imaging, and electrophysiological approaches, we identify the tetraspanin LHFPL4 as a critical regulator of postsynaptic GABAAR clustering in hippocampal pyramidal neurons. LHFPL4 interacts tightly with GABAAR subunits and is selectively enriched at inhibitory synapses. In LHFPL4 knockout mice, there is a dramatic cell-type-specific reduction in GABAAR and gephyrin clusters and an accumulation of large intracellular gephyrin aggregates in vivo. While GABAARs are still trafficked to the neuronal surface in pyramidal neurons, they are no longer localized at synapses, resulting in a profound loss of fast inhibitory postsynaptic currents. Hippocampal interneuron currents remain unaffected. Our results establish LHFPL4 as a synapse-specific tetraspanin essential for inhibitory synapse function and provide fresh insights into the molecular make-up of inhibitory synapses.


Assuntos
Proteínas de Transporte/genética , Potenciais Pós-Sinápticos Inibidores/fisiologia , Proteínas de Membrana/genética , Subunidades Proteicas/genética , Receptores de GABA-A/genética , Sinapses/metabolismo , Tetraspaninas/genética , Animais , Região CA1 Hipocampal/citologia , Região CA1 Hipocampal/metabolismo , Células COS , Proteínas de Transporte/metabolismo , Chlorocebus aethiops , Embrião de Mamíferos , Feminino , Regulação da Expressão Gênica , Interneurônios/citologia , Interneurônios/metabolismo , Masculino , Proteínas de Membrana/metabolismo , Camundongos , Técnicas de Patch-Clamp , Agregados Proteicos , Subunidades Proteicas/metabolismo , Transporte Proteico , Células Piramidais/citologia , Células Piramidais/metabolismo , Ratos , Receptores de GABA-A/metabolismo , Tetraspaninas/metabolismo , Técnicas de Cultura de Tecidos
7.
Front Neural Circuits ; 7: 203, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24391550

RESUMO

We have made use of the δ subunit-selective allosteric modulator DS2 (4-chloro-N-[2-(2-thienyl)imidazo[1,2-a]pyridine-3-yl benzamide) to assay the contribution of δ-GABAARs to tonic and phasic conductance changes in the cerebellum, thalamus and neocortex. In cerebellar granule cells, an enhancement of the tonic conductance was observed for DS2 and the orthosteric agonist THIP (4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol). As expected, DS2 did not alter the properties of GABAA receptor-mediated inhibitory postsynaptic synaptic conductances (IPSCs) supporting a purely extrasynaptic role for δ-GABAARs in cerebellar granule cells. DS2 also enhanced the tonic conductance recorded from thalamic relay neurons of the visual thalamus with no alteration in IPSC properties. However, in addition to enhancing the tonic conductance DS2 also slowed the decay of IPSCs recorded from layer II/III neocortical neurons. A slowing of the IPSC decay also occurred in the presence of the voltage-gated sodium channel blocker TTX. Moreover, under conditions of reduced GABA release the ability of DS2 to enhance the tonic conductance was attenuated. These results indicate that δ-GABAARs can be activated following vesicular GABA release onto neocortical neurons and that the actions of DS2 on the tonic conductance may be influenced by the ambient GABA levels present in particular brain regions.


Assuntos
Cerebelo/fisiologia , Neocórtex/fisiologia , Condução Nervosa/fisiologia , Receptores de GABA-A/metabolismo , Tálamo/fisiologia , Animais , Cerebelo/metabolismo , Agonistas de Receptores de GABA-A/farmacologia , Potenciais Pós-Sinápticos Inibidores/efeitos dos fármacos , Potenciais Pós-Sinápticos Inibidores/fisiologia , Camundongos , Neocórtex/metabolismo , Inibição Neural/efeitos dos fármacos , Inibição Neural/fisiologia , Neurônios/efeitos dos fármacos , Neurônios/fisiologia , Receptores de GABA-A/genética , Tálamo/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA